Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
For businesses in this space, proactive legal counsel is no longer optional
IQVIAs Integrated Performance Tracker: Obesity These primary research findings are derived from IQVIAs Integrated Performance Tracker: Obesity, a dedicated, multi-dimensional and multi-country tracking of the evolving market for obesity prescription medications and the performance of individual brands and molecules
Originally developed for type 2 diabetes management, Semaglutide gained widespread attention after the STEP 1 clinical trial (NEJM, 2021) demonstrated an average weight loss of 14.9% of body weight over 68 weeks at the 2.4mg weekly dose
Please click the checkbox below
US$ 25.42
US$ 26.15
US$ 25.95
US$ 21.21
US$ 22.85
US$ 23.53
US$ 2725.00
Sold : Login>>
